{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:15:50Z","timestamp":1793304950424,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003872","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000}}],"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50120C00096"],"award-info":[{"award-number":["75A50120C00096"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002377"],"award-info":[{"award-number":["UL1TR002377"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5R35HL139854"],"award-info":[{"award-number":["5R35HL139854"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1F32HL154320"],"award-info":[{"award-number":["1F32HL154320"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["PDF-532926-2019"],"award-info":[{"award-number":["PDF-532926-2019"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32DK07352"],"award-info":[{"award-number":["5T32DK07352"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI145356"],"award-info":[{"award-number":["R21 AI145356"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI152318"],"award-info":[{"award-number":["R21 AI152318"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI154927"],"award-info":[{"award-number":["R21 AI154927"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI152078 9"],"award-info":[{"award-number":["R01 AI152078 9"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1 HL059842"],"award-info":[{"award-number":["RO1 HL059842"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. While randomized clinical trials were in various stages of development and enrollment, there was an urgent need for widespread access to potential therapeutic agents. The objective of this study is to report on the demographic, geographical, and chronological characteristics of patients in the EAP, and key safety metrics following transfusion of COVID-19 convalescent plasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>Mayo Clinic served as the central institutional review board for all participating facilities, and any US physician could participate as a local physician\u2013principal investigator. Eligible patients were hospitalized, were aged 18 years or older, and had\u2014or were at risk of progression to\u2014severe or life-threatening COVID-19; eligible patients were enrolled through the EAP central website. Blood collection facilities rapidly implemented programs to collect convalescent plasma for hospitalized patients with COVID-19. Demographic and clinical characteristics of all enrolled patients in the EAP were summarized. Temporal patterns in access to COVID-19 convalescent plasma were investigated by comparing daily and weekly changes in EAP enrollment in response to changes in infection rate at the state level. Geographical analyses on access to convalescent plasma included assessing EAP enrollment in all national hospital referral regions, as well as assessing enrollment in metropolitan areas and less populated areas that did not have access to COVID-19 clinical trials. From April 3 to August 23, 2020, 105,717 hospitalized patients with severe or life-threatening COVID-19 were enrolled in the EAP. The majority of patients were 60 years of age or older (57.8%), were male (58.4%), and had overweight or obesity (83.8%). There was substantial inclusion of minorities and underserved populations: 46.4% of patients were of a race other than white, and 37.2% of patients were of Hispanic ethnicity. Chronologically and geographically, increases in the number of both enrollments and transfusions in the EAP closely followed confirmed infections across all 50 states. Nearly all national hospital referral regions enrolled and transfused patients in the EAP, including both in metropolitan and in less populated areas. The incidence of serious adverse events was objectively low (&lt;1%), and the overall crude 30-day mortality rate was 25.2% (95% CI, 25.0% to 25.5%). This registry study was limited by the observational and pragmatic study design that did not include a control or comparator group; thus, the data should not be used to infer definitive treatment effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that the EAP provided widespread access to COVID-19 convalescent plasma in all 50 states, including for underserved racial and ethnic minority populations. The study design of the EAP may serve as a model for future efforts when broad access to a treatment is needed in response to an emerging infectious disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov NCT#:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04338360\" xlink:type=\"simple\">NCT04338360<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003872","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T13:55:29Z","timestamp":1640008529000},"page":"e1003872","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-3538","authenticated-orcid":true,"given":"Jonathon W.","family":"Senefeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-1375","authenticated-orcid":true,"given":"Patrick W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-6823","authenticated-orcid":true,"given":"Katie L.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":true,"given":"Evan M.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-4754","authenticated-orcid":true,"given":"Noud","family":"van Helmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-7782","authenticated-orcid":true,"given":"Michael A.","family":"Golafshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-8728","authenticated-orcid":true,"given":"Stephen A.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8852-4666","authenticated-orcid":true,"given":"Allan M.","family":"Klompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-1308","authenticated-orcid":true,"given":"Juan C.","family":"Diaz Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-8211","authenticated-orcid":true,"given":"Brenda J.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A. R.","family":"Tobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9653-9905","authenticated-orcid":true,"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-0142","authenticated-orcid":true,"given":"Chad C.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-6059","authenticated-orcid":true,"given":"Katelyn A.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"van Buskirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-3732","authenticated-orcid":true,"given":"Jeffrey L.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9167","authenticated-orcid":true,"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel S.","family":"Paneth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-4821","authenticated-orcid":true,"given":"Beth H.","family":"Shaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly M.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Sachais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-0989","authenticated-orcid":true,"given":"Matthew R.","family":"Buras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj A.","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Russoniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1715-0748","authenticated-orcid":true,"given":"Larry J.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-7660","authenticated-orcid":true,"given":"Sarah E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph R.","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R. A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pampee P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Verdun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-4404","authenticated-orcid":true,"given":"Peter","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-1800","authenticated-orcid":true,"given":"N. Rebecca","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-0651","authenticated-orcid":true,"given":"Vitaly","family":"Herasevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan A.","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-0549","authenticated-orcid":true,"given":"Emily R.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-1805","authenticated-orcid":true,"given":"Andrew J.","family":"Clayburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-3436","authenticated-orcid":true,"given":"Mary Kathryn","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-3318","authenticated-orcid":true,"given":"Kathryn F.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-2871","authenticated-orcid":true,"given":"Kylie J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-8451","authenticated-orcid":true,"given":"Matthew N. P.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-9006","authenticated-orcid":true,"given":"Joshua J.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-5875","authenticated-orcid":true,"given":"Riley J.","family":"Regimbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-3581","authenticated-orcid":true,"given":"Philippe R.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis E.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5450-6072","authenticated-orcid":true,"given":"Zachary A.","family":"Buchholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-0614","authenticated-orcid":true,"given":"Michaela C.","family":"Pletsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Greenshields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Joyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-273X","authenticated-orcid":true,"given":"Rickey E.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-1810","authenticated-orcid":true,"given":"DeLisa","family":"Fairweather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"pmed.1003872.ref001","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(20)30863-1","article-title":"COVID-19 in the USA: a question of time","volume":"395","author":"The Lancet","year":"2020","journal-title":"Lancet"},{"key":"pmed.1003872.ref002","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review","volume":"173","author":"DP Oran","year":"2020","journal-title":"Ann Intern Med"},{"key":"pmed.1003872.ref003","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2021.01.020","article-title":"SARS-CoV-2 infection hospitalization rate and infection fatality rate among the non-congregate population in Connecticut","volume":"134","author":"S Mahajan","year":"2021","journal-title":"Am J Med"},{"key":"pmed.1003872.ref004","doi-asserted-by":"crossref","first-page":"e2033706","DOI":"10.1001\/jamanetworkopen.2020.33706","article-title":"Estimation of US SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys","volume":"4","author":"FJ Angulo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pmed.1003872.ref005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/PHH.0000000000001331","article-title":"How many SARS-CoV-2-infected people require hospitalization? Using random sample testing to better inform preparedness efforts","volume":"27","author":"N Menachemi","year":"2021","journal-title":"J Public Health Manag Pract"},{"key":"pmed.1003872.ref006","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"S Richardson","year":"2020","journal-title":"JAMA"},{"key":"pmed.1003872.ref007","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"S Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"key":"pmed.1003872.ref008","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","article-title":"COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?","volume":"8","author":"E Fan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"pmed.1003872.ref009","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.mayocp.2021.02.008","article-title":"The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis","volume":"96","author":"SA Klassen","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"pmed.1003872.ref010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinmicnews.2021.02.001","article-title":"Convalescent plasma for infectious diseases: historical framework and use in COVID-19.","volume":"43","author":"J Ripoll Sanz","year":"2021","journal-title":"Clin Microbiol Newsl"},{"key":"pmed.1003872.ref011","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections.","volume":"38","author":"TC Luke","year":"2010","journal-title":"Crit Care Med"},{"key":"pmed.1003872.ref012","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.38.8.1695","article-title":"Serum therapy revisited: animal models of infection and development of passive antibody therapy","volume":"38","author":"A Casadevall","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1003872.ref013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","article-title":"Return to the past: the case for antibody-based therapies in infectious diseases","volume":"21","author":"A Casadevall","year":"1995","journal-title":"Clin Infect Dis"},{"key":"pmed.1003872.ref014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Y Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pmed.1003872.ref015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"C Shen","year":"2020","journal-title":"JAMA"},{"key":"pmed.1003872.ref016","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","author":"L Li","year":"2020","journal-title":"JAMA"},{"key":"pmed.1003872.ref017","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.ajpath.2020.05.014","article-title":"Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma","volume":"190","author":"E Salazar","year":"2020","journal-title":"Am J Pathol"},{"key":"pmed.1003872.ref018","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","article-title":"Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study","volume":"26","author":"STH Liu","year":"2020","journal-title":"Nat Med"},{"key":"pmed.1003872.ref019","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1056\/NEJMp2023616","article-title":"Structural racism, social risk factors, and Covid-19\u2014a dangerous convergence for Black Americans","volume":"383","author":"LE Egede","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1003872.ref020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMp2019445","article-title":"Covid\u2019s color line\u2014infectious disease, inequity, and racial justice","volume":"383","author":"MK Evans","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1003872.ref021","unstructured":"Expanded Access Program. Protocol. Rochester (MN): Mayo Clinic; 2021 [cited 2021 Dec 15]. Available from: https:\/\/www.uscovidplasma.org\/physicians-protocol."},{"key":"pmed.1003872.ref022","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from Covid-19","volume":"384","author":"MJ Joyner","year":"2021","journal-title":"N Engl J Med"},{"key":"pmed.1003872.ref023","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients","volume":"95","author":"MJ Joyner","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"pmed.1003872.ref024","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5000 patients","volume":"130","author":"MJ Joyner","year":"2020","journal-title":"J Clin Invest"},{"key":"pmed.1003872.ref025","unstructured":"Expanded Access Program. Rochester (MN): Mayo Clinic; 2021 [cited 2021 Dec 15]. Available from: https:\/\/www.uscovidplasma.org."},{"key":"pmed.1003872.ref026","unstructured":"Code of Federal Regulations Title 21: Chapter I\u2014Subchapter A. Part 50\u2014protection of human subjects. Subpart B\u2014informed consent of human subjects. \u00a750.23. Exception from general requirements. College Park (MD): National Archives; 2021 [cited 2021 Aug 4]. Available from: https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-A\/part-50#50.23."},{"key":"pmed.1003872.ref027","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"pmed.1003872.ref028","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"pmed.1003872.ref029","volume-title":"Revisions to the standards for the classification of federal data on race and ethnicity","author":"Office of Management and Budget","year":"1997"},{"key":"pmed.1003872.ref030","author":"US Census Bureau","year":"2018"},{"key":"pmed.1003872.ref031","author":"The New York Times","year":"2021"},{"key":"pmed.1003872.ref032","author":"Dartmouth Atlas Data","year":"2021"},{"key":"pmed.1003872.ref033","volume-title":"2010 standards for delineating metropolitan and micropolitan statistical areas","author":"Office of Management and Budget","year":"2010"},{"key":"pmed.1003872.ref034","volume-title":"United States regions.","author":"SP O\u2019Connor","year":"2012"},{"key":"pmed.1003872.ref035","author":"American Hospital Directory","year":"2021"},{"key":"pmed.1003872.ref036","author":"Centers for Medicare & Medicaid Services","year":"2021"},{"key":"pmed.1003872.ref037","author":"Division of Healthcare Quality Promotion","year":"2021"},{"key":"pmed.1003872.ref038","volume-title":"Convalescent plasma EUA letter of authorization","author":"DM Hinton","year":"2021"},{"key":"pmed.1003872.ref039","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15585\/mmwr.mm6918e1","article-title":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19\u2014Georgia, March 2020.","volume":"69","author":"JAW Gold","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pmed.1003872.ref040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.2020.7202","article-title":"Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California","volume":"323","author":"LC Myers","year":"2020","journal-title":"JAMA"},{"key":"pmed.1003872.ref041","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and mortality among black patients and white patients with Covid-19","volume":"382","author":"EG Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1003872.ref042","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamainternmed.2020.3857","article-title":"Assessment of COVID-19 hospitalizations by race\/ethnicity in 12 states","volume":"181","author":"P Karaca-Mandic","year":"2021","journal-title":"JAMA Intern Med"},{"key":"pmed.1003872.ref043","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.15585\/mmwr.mm6933e2","article-title":"Trends in number and distribution of COVID-19 hotspot counties\u2014United States, March 8\u2013July 15, 2020.","volume":"69","author":"AM Oster","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pmed.1003872.ref044","first-page":"66","article-title":"The assessment of convalescent plasma efficacy against COVID-19","volume":"1","author":"A Casadevall","year":"2020","journal-title":"Med (N Y)."},{"key":"pmed.1003872.ref045","unstructured":"Code of Federal Regulations Title 21: Chapter I\u2014Subchapter D. Part 312\u2014Investigational new drug application. Subpart I\u2014Expanded access to investigational drugs for treatment use. College Park (MD): National Archives; 2021 [cited 2021 Aug 4]. Available from: https:\/\/www.ecfr.gov\/cgi-bin\/text-idx?SID=40cb0c2fa8a160e0b772e49d93aab406&mc=true&node=sp21.5.312.i&rgn=div6."},{"key":"pmed.1003872.ref046","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"JH Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1003872.ref047","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-016-0760-x","article-title":"Modernising epidemic science: enabling patient-centred research during epidemics","volume":"14","author":"AM Rojek","year":"2016","journal-title":"BMC Med"},{"key":"pmed.1003872.ref048","first-page":"18s","article-title":"Participation of racial\/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995\u20131999","volume":"93","author":"B Evelyn","year":"2001","journal-title":"J Natl Med Assoc"},{"key":"pmed.1003872.ref049","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4155\/cli.14.21","article-title":"Geographic distribution of clinical trials may lead to inequities in access","volume":"4","author":"EM Seidler","year":"2014","journal-title":"Clin Invest"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003872","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T13:41:00Z","timestamp":1641390060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003872"}},"subtitle":[],"editor":[{"given":"Cynthia","family":"So\u2010Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003872","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.08.21255115","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}